Zymeworks (ZYME) Net Margin Growth (1y) (2022 - 2026)

Zymeworks (ZYME) Net Margin Growth (1y) (2022 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin Growth (1y) (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 1,491.00
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 1,120.00
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -653.00
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 447.00
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Zymeworks 1.73 Bn 1.36 Bn - -175,047.00

Historic Data

Download Data
DateValue
Mar 31, 2026 -175,047.00
Dec 31, 2025 -156,278.00
Sep 30, 2025 11,558.00
Jun 30, 2025 20,060.00
Mar 31, 2025 23,209.00
Dec 31, 2024 981.00
Sep 30, 2024 -1,277.00
Jun 30, 2024 53,469.00
Mar 31, 2024 -24,713.00
Dec 31, 2023 -18,077.00
Sep 30, 2023 164,475.00
Jun 30, 2023 45,688.00
Mar 31, 2023 372,200.00
Dec 31, 2022 58,461.00
Sep 30, 2022 -44,019.00